2020
Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
Higgins AY, Annapureddy AR, Wang Y, Minges KE, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy. Journal Of The American Heart Association 2020, 9: e016038. PMID: 32867553, PMCID: PMC7726970, DOI: 10.1161/jaha.120.016038.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillator implantationCardioverter-defibrillator implantationNonischemic cardiomyopathyCardiac amyloidosisDiabetes mellitusCerebrovascular diseaseVentricular tachycardiaMultivariable Cox proportional hazards regression modelsCox proportional hazards regression modelProportional hazards regression modelsKaplan-Meier survival curvesCox proportional hazards modelPropensity-matched cohortOutcomes of patientsHazards regression modelsProportional hazards modelCause mortalityICD implantationRenal functionMultivariable analysisConclusions MortalityRisk factorsRegistry dataAmyloid cardiomyopathyHigh risk
2015
Use of Remote Monitoring Is Associated With Lower Risk of Adverse Outcomes Among Patients With Implanted Cardiac Defibrillators
Akar JG, Bao H, Jones PW, Wang Y, Varosy PD, Masoudi FA, Stein KM, Saxon LA, Normand SL, Curtis JP. Use of Remote Monitoring Is Associated With Lower Risk of Adverse Outcomes Among Patients With Implanted Cardiac Defibrillators. Circulation Arrhythmia And Electrophysiology 2015, 8: 1173-1180. PMID: 26092577, DOI: 10.1161/circep.114.003030.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillatorInitial implantable cardioverter defibrillatorCause mortalityLower riskAdverse outcomesNational Cardiovascular Data Registry ICD RegistryRemote patient monitoringSocial Security Death Master FileCause rehospitalization rateRisk of rehospitalizationImplanted cardiac defibrillatorsDeath Master FileCardiomyopathy pathogenesisCause rehospitalizationICD RegistryRehospitalization ratesMultivariable analysisStudy cohortVital statusService patientsCardioverter defibrillatorCox modelMedicare populationMedicare feePatientsFrequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study)
Gupta A, Chui P, Zhou S, Spertus JA, Geda M, Lorenze N, Lee I, Onofrio G, Lichtman JH, Alexander KP, Krumholz HM, Curtis JP. Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study). The American Journal Of Cardiology 2015, 116: 1-7. PMID: 25937348, PMCID: PMC4466069, DOI: 10.1016/j.amjcard.2015.03.032.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge DistributionAngioplasty, Balloon, CoronaryAnticoagulantsAntithrombinsBody Mass IndexCohort StudiesFemaleHemorrhageHeparinHirudinsHumansMaleMiddle AgedMyocardial InfarctionPeptide FragmentsPercutaneous Coronary InterventionPlatelet Glycoprotein GPIIb-IIIa ComplexPrevalenceRecombinant ProteinsRisk AssessmentRisk FactorsSex DistributionTreatment OutcomeUnited StatesConceptsPercutaneous coronary interventionGlycoprotein IIb/IIIa inhibitorsIIb/IIIa inhibitorsExcess dosingAcute myocardial infarctionCoronary interventionMultivariable analysisMyocardial infarctionUnderwent Percutaneous Coronary InterventionLower body weightOlder patientsYounger patientsUnfractionated heparinMedical recordsUnivariate analysisAnticoagulant agentsAnticoagulant drugsBody weightPatientsDosingYounger ageLogistic regressionYoung womenAnticoagulantsGender-based differences
2013
Safety of Pacemaker Implantation in Nonagenarians
Mandawat A, Curtis JP, Mandawat A, Njike VY, Lampert R. Safety of Pacemaker Implantation in Nonagenarians. Circulation 2013, 127: 1453-1465. PMID: 23513066, DOI: 10.1161/circulationaha.113.001434.Peer-Reviewed Original ResearchMeSH KeywordsAge DistributionAgedAged, 80 and overArrhythmias, CardiacComorbidityCross-Sectional StudiesFemaleHealth Care CostsHospital MortalityHumansLength of StayLinear ModelsLogistic ModelsMaleMultivariate AnalysisOutcome and Process Assessment, Health CarePacemaker, ArtificialPredictive Value of TestsUnited StatesConceptsLength of stayYears of ageSevere comorbiditiesPacemaker implantationUtilization Project Nationwide Inpatient SampleInitial pacemaker implantationCase-mix variationMantel-Haenszel testStepwise linear regression modelHospital mortalityUnadjusted mortalityComplication rateMultivariable analysisUnadjusted outcomesInpatient SampleHealthcare costsPatientsComorbiditiesHierarchical logistic modelsStayNonagenariansMortalityAgeOutcomesComplications
2012
Bleeding-Avoidance Strategies and Outcomes in Patients ≥80 Years of Age With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the NCDR CathPCI Registry)
Dodson JA, Wang Y, Chaudhry SI, Curtis JP. Bleeding-Avoidance Strategies and Outcomes in Patients ≥80 Years of Age With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the NCDR CathPCI Registry). The American Journal Of Cardiology 2012, 110: 1-6. PMID: 22475362, PMCID: PMC3666171, DOI: 10.1016/j.amjcard.2012.02.039.Peer-Reviewed Original ResearchConceptsPrimary percutaneous coronary interventionPrimary PCIBleeding-avoidance strategiesST-segment elevation myocardial infarctionElevation myocardial infarctionPercutaneous coronary interventionMyocardial infarctionCoronary interventionUndergoing primary percutaneous coronary interventionST-elevation myocardial infarctionDirect thrombin inhibitorVascular closure deviceYears of ageBleeding complicationsCathPCI RegistryMultivariable analysisRadial accessClosure deviceHigh riskBleedingPatientsThrombin inhibitorsInfarctionLow bleedingStudy period
2011
Use and Effectiveness of Intra-Aortic Balloon Pumps Among Patients Undergoing High Risk Percutaneous Coronary Intervention
Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM. Use and Effectiveness of Intra-Aortic Balloon Pumps Among Patients Undergoing High Risk Percutaneous Coronary Intervention. Circulation Cardiovascular Quality And Outcomes 2011, 5: 21-30. PMID: 22147887, PMCID: PMC3801197, DOI: 10.1161/circoutcomes.110.960385.Peer-Reviewed Original ResearchConceptsHigh-risk percutaneous coronary interventionIntra-aortic balloon pumpPercutaneous coronary interventionHospital quartilesHospital mortalityIABP useCoronary interventionBalloon pumpHospital characteristicsST-segment elevation myocardial infarctionDepressed left ventricular functionHigh-risk PCI patientsSegment elevation myocardial infarctionElevation myocardial infarctionLeft ventricular functionHierarchical logistic regression modelsLogistic regression modelsIABP usageCardiogenic shockPCI patientsCathPCI RegistryHemodynamic supportVentricular functionHospital variationMultivariable analysis
2009
Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation
Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA, Registry C. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 2009, 6: 1565-1571. PMID: 19879533, DOI: 10.1016/j.hrthm.2009.08.006.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillator implantationESRD patientsCardioverter-defibrillator implantationICD implantationHospital complicationsTotal complicationsHospital stayPrimary preventionEnd-stage renal disease patientsEnd-stage renal diseaseComorbid medical conditionsRenal disease patientsHigh rateERSD patientsHospital mortalityHospital outcomesClinical characteristicsAngiotensin inhibitorsClinical profileICD RegistryMajor complicationsPrimary outcomeRenal diseaseMultivariable analysisDevice implantationUse of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria?
Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA, behalf of the NCDR O. Use of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria? American Heart Journal 2009, 158: 224-229. PMID: 19619698, DOI: 10.1016/j.ahj.2009.05.018.Peer-Reviewed Original ResearchConceptsTrial enrollment criteriaPrimary prevention ICD implantationEnrollment criteriaICD implantationMADIT-IIMultivariable analysisPrimary preventionTrial criteriaNational Cardiovascular Data Registry ICD RegistryPrimary prevention ICD placementImplantable cardioverter defibrillator implantationSCD-HeFT trialsCardioverter-defibrillator implantationSudden cardiac deathImplantable cardioverter defibrillatorDefibrillator implantationSCD-HeFTYounger patientsCardiac deathICD RegistryICD placementNational cohortCardioverter defibrillatorOlder womenPatientsGender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy
Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy. Circulation 2009, 119: 1078-1084. PMID: 19221223, DOI: 10.1161/circulationaha.108.793463.Peer-Reviewed Original ResearchConceptsHospital adverse eventsImplantable cardioverter-defibrillator therapyMajor adverse eventsAdverse eventsCardioverter-defibrillator therapyICD implantationHigh riskNational Cardiovascular Data Registry ICD RegistryNew York Heart Association functional statusFirst-time ICD implantationAdverse event ratesInvasive cardiac proceduresHeart failureICD RegistryNonischemic cardiomyopathyMultivariable analysisCardiac proceduresUnadjusted analysesFunctional statusHospital characteristicsBiventricular ICDsMultivariable modelEvent ratesPatientsWomen
2004
The Prognostic Value of Vasodilator Myocardial Perfusion Imaging in Octogenarians
Curtis JP, Ko DT, Wang Y, Wackers FJ, Foody JM. The Prognostic Value of Vasodilator Myocardial Perfusion Imaging in Octogenarians. The American Journal Of Geriatric Cardiology 2004, 13: 239-245. PMID: 15365286, DOI: 10.1111/j.1076-7460.2004.03126.x.Peer-Reviewed Original ResearchConceptsMyocardial perfusion imagingPerfusion imagingVasodilator myocardial perfusion imagingAbnormal myocardial perfusion imagingTomography myocardial perfusion imagingMortality of octogenariansSPECT myocardial perfusion imagingLarge perfusion defectsSingle photon emissionStress defectsAggressive managementCrude mortalityMultivariable analysisPrognostic valuePerfusion defectsCardiac diseaseOctogenariansDefect reversibilityMortalitySPECT imagingStrongest predictorPhoton emissionImagingPatientsDiseaseThe association of 6-minute walk performance and outcomes in stable outpatients with heart failure.
Curtis JP, Rathore SS, Wang Y, Krumholz HM. The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. Journal Of Cardiac Failure 2004, 10: 9-14. PMID: 14966769, DOI: 10.1016/s1071-9164(03)00705-x.Peer-Reviewed Original ResearchThe association of 6-minute walk performance and outcomes in stable outpatients with heart failure
Curtis J, Rathore S, Wang Y, Krumholz H. The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. Journal Of Cardiac Failure 2004, 10: 9-14. DOI: 10.1016/j.cardfail.2003.08.010.Peer-Reviewed Original ResearchHeart failureWalk testStable outpatientsDigitalis Investigation Group trialRisk of deathCause mortalityIdentifies patientsMultivariable analysisPrognostic valuePrognostic informationGroup trialsWalk performancePatientsTest distanceMortalityDeathOutpatientsOutcomesFailureAssociationBackgroundWeTrialsMonths